EMA — authorised 20 June 2019
- Marketing authorisation holder: MYLAN SAS
- Status: approved
🇪🇺 Letairis in European Union
EMA authorised Letairis on 20 June 2019
Marketing authorisation
Letairis in other countries
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Other Cardiovascular approved in European Union
Frequently asked questions
Is Letairis approved in European Union?
Yes. EMA authorised it on 20 June 2019.
Who is the marketing authorisation holder for Letairis in European Union?
MYLAN SAS holds the EU marketing authorisation.